Rockwell Medical Inc (RMTI)
Official siteHEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ
Market Cap: $27.92M
Last updated: Nov 17, 2026 at 4:10 PM ET
Rockwell Medical Inc (RMTI) Statistics
Rockwell Medical (RMTI) has a market cap of $27.92M and an enterprise value of $26.34M. Its share count is up 10.26% from a year earlier.
Total Valuation
Enterprise value is 5.66% below the market cap, as cash exceeds debt.
| Market Cap | $27.92M |
|---|---|
| Enterprise Value | $26.34M |
| Latest price (Nov 17, 2026) | $6.61 |
Key Dates
The next earnings report is expected on Mar 24, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Mar 24, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 12, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 0.4x and 0.8x. Its year-end P/S ranged from 0.2x to 8.2x from 2016 to 2025.
| P/S Ratio | 0.4x |
|---|---|
| Forward P/S | 0.4x |
| P/B Ratio | 0.8x |
| P/TBV Ratio | 1.1x |
| P/FCF Ratio | 31.7x |
| P/OCF Ratio | 10.4x |
Enterprise Valuation
Counting debt and cash, the company is valued at 29.8x free cash flow.
| EV / Sales | 0.4x |
|---|---|
| EV / FCF | 29.8x |
Price Statistics
The stock is down 28.08% over 52 weeks and trades 14.71% below its 50-day average.
| Beta (1Y) | 0.58 |
|---|---|
| 52-Week Change | -28.08% |
| 1-Month Change | -11.75% |
| 3-Month Change | -11.87% |
| 6-Month Change | -17.21% |
| 5-Year Change | -88.02% |
| 10-Year Change | -98.89% |
| Total Return (1Y) | -28.08% |
| Total Return (3Y CAGR) | -31.64% |
| Total Return (5Y CAGR) | -34.45% |
| Return vs SPY (1Y) | -36.03% |
| Max Drawdown (1Y) | -58.81% |
| Max Drawdown (3Y) | -88.84% |
| Sharpe Ratio (1Y) | -0.42 |
| Correlation with SPY (1Y) | 0.12 |
| 50-Day Average | $7.75 |
| 200-Day Average | $8.01 |
| 52-Week Range | $4.88 to $12.90 |
| RSI (14 Days) | 38.4 |
| Average Volume (20 Days) | 23.23K |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 2.47x current liabilities, and total debt is 0.27x shareholder equity.
| Current Ratio | 2.47x |
|---|---|
| Quick Ratio | 2.27x |
| Debt / Equity | 0.27x |
| Debt / FCF | 10.93x |
| Interest Coverage | 0.54x |
Returns and Efficiency
Return on invested capital is -8.79% over the last 12 months, against a 5-year average of -36.45%.
| Return on Equity (ROE) | -17.07% |
|---|---|
| Return on Assets (ROA) | -9.91% |
| Return on Invested Capital (ROIC) | -8.79% |
| Return on Capital Employed (ROCE) | -11.18% |
| ROA (5Y Average) | -26.72% |
| ROIC (5Y Average) | -36.45% |
| Asset Turnover | 1.27x |
| Inventory Turnover | 20.67x |
| Receivables Turnover | 8.02x |
| Cash Conversion Cycle | 42 days |
Scores
RMTI has an Altman Z-Score of -7.89, in the distress zone below 1.81, and a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | -7.89 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 2 of 9 |
| Piotroski Strength | Weak |
Income Statement
Revenue of $72.58M over the last 12 months is down 3.96% from the 12 months before.
| Revenue | $72.58M |
|---|---|
| Revenue Growth (YoY) | -3.96% |
| Gross Profit | $13.13M |
| Operating Income | -$5.16M |
| Pretax Income | -$5.66M |
| Net Income | -$5.66M |
| EBITDA | -$2.28M |
| EBIT | -$4.70M |
| Reported EPS (TTM) | -$1.34 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 58.04% of the $57.08M in total assets.
| Cash and Equivalents | $10.63M |
|---|---|
| Total Debt | $9.05M |
| Net Cash | $1.58M |
| Net Cash Per Share | $0.40 |
| Working Capital | $22.10M |
| Shareholder Equity | $33.13M |
| Book Value Per Share | $8.34 |
| Tangible Book Value | $22.97M |
| Tangible Book Per Share | $5.78 |
| Total Assets | $57.08M |
| Total Liabilities | $23.95M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $1.85M of capital spending, operating cash flow left $828.00K of free cash flow.
| Operating Cash Flow | $2.68M |
|---|---|
| Capital Expenditures | $1.85M |
| Free Cash Flow | $828.00K |
| FCF Per Share | $0.21 |
| Depreciation and Amortization | $2.41M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is -7.11%, against a 5-year average of -17.24%.
| Gross Margin | 18.09% |
|---|---|
| Operating Margin | -7.11% |
| Pretax Margin | -7.79% |
| Net Margin | -7.79% |
| EBITDA Margin | -3.15% |
| EBIT Margin | -6.47% |
| FCF Margin | 1.14% |
| Gross Margin (5Y Average) | 9.24% |
| Operating Margin (5Y Average) | -17.24% |
| Net Margin (5Y Average) | -19.33% |
Growth
Revenue fell 1.65% a year over 3 years.
| Revenue Growth (3Y CAGR) | -1.65% |
|---|---|
| Revenue Growth (5Y CAGR) | +2.17% |
| Book Value Per Share Growth (2Y CAGR) | +12.38% |
| Tangible Book Per Share Growth (2Y CAGR) | +41.34% |
Dividends and Yields
RMTI does not pay a dividend. Its free cash flow yield is 3.15%.
| FCF Yield | 3.15% |
|---|---|
| Shareholder Yield | 0.00% |
Stock Splits
The last split was a 1-for-10 reverse split on Jul 1, 2026.
| Last Split Date | Jul 1, 2026 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:10 |
Peer Position
Against 8 similar companies, RMTI has the 7th highest P/S and the 3rd highest ROIC.
P/S RatioPeer median 1.7x
ROICPeer median -28.50%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +13.87%
| P/S Ratio | 0.4x vs 1.7x median |
|---|---|
| ROIC | -8.79% vs -28.50% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | -3.96% vs +13.87% median |
Analyst Forecast
Consensus estimates put revenue growth at 6.54% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +6.54% |
|---|
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About RMTI
What is RMTI's market cap?
Rockwell Medical has a market cap of $27.92M. Its enterprise value, which adds debt and subtracts cash, is $26.34M.
How many shares of RMTI are outstanding?
Rockwell Medical has 3.97M shares outstanding. The count is up 10.26% from a year earlier.
Does RMTI pay a dividend?
No. Rockwell Medical does not pay a dividend.
How much debt does RMTI have?
Rockwell Medical has $9.05M of total debt and $10.63M of cash and equivalents, a net cash position of $1.58M.
RMTI pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors, Government Contracts